FCF Valuation Monitor – Q3 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q3 2021”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
FCF Life Sciences Venture Capital Monitor – Europe 09/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 09/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life
FCF Metals & Materials Market Study – 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Metals & Materials Market Study – 2021”. FCF regularly engages in research on the metals & materials sector based on available data from
FCF Life Sciences acts as sole financial advisor to Precisis AG in a EUR 20m financing round with Cochlear Ltd.
Munich, 11th October 2021 – FCF Life Sciences, part of FCF Fox Corporate Finance GmbH, acts as sole financial advisor to Precisis AG, a leading neurostimulation company, in the execution of a financing transaction of
FCF European Chemicals Market Study – 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF European Chemicals Market Study – 2021”. FCF regularly engages in research on the chemicals sector based on available data from European chemical firms.
FCF Biotech Venture Capital Monitor – USA 08/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 08/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences Venture Capital Monitor – Europe 08/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 08/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life
Corona slows down the business of foreign banks | Handelsblatt 03.09.2021 – Quotes by FCF
CORONA SLOWS DOWN THE BUSINESS OF FOREIGN BANKS | HANDELSBLATT 03.09.2021 – QUOTES BY FCF On September 3, 2021, Handelsblatt reports online on the corporate banking business of German banks and their foreign competitors. The
Venture capital financing of European life sciences companies could exceed the EUR 10 billion mark in 2021 for the first time
Venture capital financing of European life sciences companies could exceed the EUR 10 billion mark in 2021 for the first time FCF Life Sciences Venture Capital Monitor: Venture capital deal volume in Europe increases to
FCF Biotech Venture Capital Monitor – USA 07/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 07/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As